Literature DB >> 13738925

The inhibitory effect of 6-azauracil riboside on the multiplication of vaccinia virus.

B RADA, D BLASKOVIC, F SORM, J SKODA.   

Abstract

Entities:  

Keywords:  NUCLEOSIDES AND NUCLEOTIDES/pharmacology; VACCINIA/virology

Mesh:

Substances:

Year:  1960        PMID: 13738925     DOI: 10.1007/bf02158350

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  7 in total

1.  The biosynthesis of 6-azauracil riboside by Escherichia coli growing in the presence of 6-azauracil.

Authors:  J SKODA; V F HESS; F SORM
Journal:  Experientia       Date:  1957-04-15

2.  Multiplication of vaccinia virus in the chorioallantoic membrane in vitro.

Authors:  J R OVERMAN; I TAMM
Journal:  Virology       Date:  1957-02       Impact factor: 3.616

3.  The anti-tumour activity of 6-azauracil riboside.

Authors:  F SORM; H KEILOVA
Journal:  Experientia       Date:  1958-06-15

4.  Selective chemical inhibition of influenza B virus multiplication.

Authors:  I TAMM
Journal:  J Bacteriol       Date:  1956-07       Impact factor: 3.490

5.  The anticancerous action of 6-azauracil (3, 5-dioxo-2, 3, 4, 5-tetrahydro-1, 2, 4-triazine).

Authors:  F SORM; A JAKUBOVIC; L SLECHTA
Journal:  Experientia       Date:  1956-07-15

6.  Microbial studies of 6-azauracil, an antagonist of uracil.

Authors:  R E HANDSCHUMACHER; A D WELCH
Journal:  Cancer Res       Date:  1956-11       Impact factor: 12.701

7.  Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. II. Measurement of inhibitory activity by hemagglutination titrations.

Authors:  I TAMM; K FOLKERS; F L HORSFALL
Journal:  J Exp Med       Date:  1953-09       Impact factor: 14.307

  7 in total
  5 in total

1.  Inhibition of vaccinia virus multiplication by 2-carboxymethylmercapto-4-amino-5-(p-chlorphenyl)-pyrimidine.

Authors:  B RADA; Z BUDESINSKY; Z PERINA
Journal:  Experientia       Date:  1963-04-15

Review 2.  New indications for 6-azauridine treatment in man. A review.

Authors:  J Elis; H Rasková
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

3.  Use of disposable micro tissue culture plates for antiviral and interferon induction studies.

Authors:  R W Sidwell; J H Huffman
Journal:  Appl Microbiol       Date:  1971-11

4.  Historical perspectives in the development of antiviral agents against poxviruses.

Authors:  Erik De Clercq
Journal:  Viruses       Date:  2010-06-14       Impact factor: 5.818

5.  4',6-Dichloroflavan (BW683C), a new anti-rhinovirus compound.

Authors:  D J Bauer; J W Selway; J F Batchelor; M Tisdale; I C Caldwell; D A Young
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.